483 Ipsen Biopharm Sep 2017

483 Ipsen Biopharm Sep 2017

Susan Hadman FDA, Shawn Larson FDA$119.00 - Available Now

FDA investigators audited the Ipsen Biopharm - Wrexham, United Kingdom facility and issued inspectional observations (via FDA 483) on 12 Sep 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 12 Sep 2017
  • Location: Wrexham, United Kingdom
  • FEI: 1000346340
Add To Cart